Literature DB >> 9581903

Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase.

P D Boucher1, R J Ruch, D S Shewach.   

Abstract

The two human colon carcinoma cell lines HT-29 and SW620, which stably express herpes simplex virus thymidine kinase (HSV-TK), are sensitized to the cytotoxic effects of the antiviral drug ganciclovir (GCV). Compared with HT-29 cells, SW620 cells were more sensitive to lower GCV concentrations (<1 microM), accumulated GCV triphosphate more rapidly, and incorporated higher levels of GCV into DNA. Following a 24-hr exposure to 10 microM GCV, bystander killing was as much as sixfold greater in SW620 cells than HT-29 cells. This bystander effect was dependent on the level of HSV-TK expression, the number of cells expressing HSV-TK, and the overall confluency of the cells. However, bystander killing did not correlate with gap junctional intercellular communication as determined by microinjection of Lucifer Yellow fluorescent dye. SW620 cells were coupled to <3% adjacent cells (compared with >50% for HT-29 cells), but were still able to transfer phosphorylated GCV to bystander cells as soon as 4 hr after drug was added. These results emphasize the importance of cell-specific metabolism in HSV-TK/GCV-mediated cytotoxicity and may suggest a novel mechanism for bystander killing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581903     DOI: 10.1089/hum.1998.9.6-801

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

Review 1.  Prodrug-activating systems in suicide gene therapy.

Authors:  C J Springer; I Niculescu-Duvaz
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  Gap junction- and hemichannel-independent actions of connexins.

Authors:  Jean X Jiang; Sumin Gu
Journal:  Biochim Biophys Acta       Date:  2004-10-22

3.  TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancer.

Authors:  Shan-Yu Guo; Qin-Long Gu; Zheng-Gang Zhu; He-Qun Hong; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

4.  Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.

Authors:  Jayoung Kim; Yechan Kang; Stephany Y Tzeng; Jordan J Green
Journal:  Acta Biomater       Date:  2016-06-01       Impact factor: 8.947

5.  Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.

Authors:  Antonella Mangraviti; Stephany Yi Tzeng; Kristen Lynn Kozielski; Yuan Wang; Yike Jin; David Gullotti; Mariangela Pedone; Nitsa Buaron; Ann Liu; David R Wilson; Sarah K Hansen; Fausto J Rodriguez; Guo-Dong Gao; Francesco DiMeco; Henry Brem; Alessandro Olivi; Betty Tyler; Jordan J Green
Journal:  ACS Nano       Date:  2015-02-10       Impact factor: 15.881

Review 6.  The role of gap junctions in inflammatory and neoplastic disorders (Review).

Authors:  Pui Wong; Victoria Laxton; Saurabh Srivastava; Yin Wah Fiona Chan; Gary Tse
Journal:  Int J Mol Med       Date:  2017-01-17       Impact factor: 4.101

7.  Sequential histopathological changes in vivo after suicide gene therapy of gastric cancer induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats.

Authors:  T Okino; M Onda; N Matsukura; K I Inada; M Tatematsu; S Suzuki; T Shimada
Journal:  Jpn J Cancer Res       Date:  2001-06

8.  Suicide gene therapy for chemically induced rat bladder tumor entailing instillation of adenoviral vectors.

Authors:  S Akasaka; S Suzuki; H Shimizu; T Igarashi; M Akimoto; T Shimada
Journal:  Jpn J Cancer Res       Date:  2001-05

9.  Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics.

Authors:  Jehad Zweiri; Stephen E Christmas
Journal:  Cancer Cell Int       Date:  2020-01-28       Impact factor: 5.722

10.  MLH1 deficiency enhances tumor cell sensitivity to ganciclovir.

Authors:  J J O'Konek; P D Boucher; A A Iacco; T E Wilson; D S Shewach
Journal:  Cancer Gene Ther       Date:  2009-03-20       Impact factor: 5.987

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.